1
|
Tantawi A, Itoda Y, Ayyat K, Okamoto T, Thuita L, Sakanoue I, Elgharably H, Yun J, McCurry K. Impact of Donor Age on Survival of Lung Transplant Recipients According to Their Primary Diagnosis. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
2
|
Huddleston S, Hertz M, Loor G, Garcha P, Hartwig M, Snyder L, Siddique A, Strah H, Kukreja J, Song T, Jablonski R, Smith M, Walia R, Arjuna A, Lozonschi L, Patel K, Katlaps G, Nemeh H, Suarez E, Huang H, Langer N, Madsen J, Lee A, Dhillon G, MacArthur J, Keshavamurthy S, Nandavaram S, Daneshmand M, Neujahr D, Bush E, Joyce D, Ardehali A, Budev M, McCurry K. Impact of National OCS Lung Procurement & Management Program on Post-Transplant Survival - Real World Data from the Thoracic Organ Perfusion (TOP) Post-Approval Registry. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
3
|
Okamoto T, Ayyat K, Sakanoue I, Tantawi A, Unai S, Ahmad U, Elgharably H, Yun J, Budev M, McCurry K. Impact of Ex Vivo Lung Perfusion on a Lung Transplant Program: A Single Center Experience. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
4
|
Shen K, You J, Wang Y, Wang X, Esfeh JM, Hashimoto K, McCurry K, Yun J, Budev M. A Single-Center Retrospective Study of Patients Undergoing Combined Liver-Lung Transplantation (LLT). J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
5
|
Ayyat K, Okamoto T, Tantawi A, Sakanoue I, Elgharably H, Ahmad U, Unai S, Yun J, Budev M, McCurry K. Back-Table Evaluation Prior to Ex-Vivo Lung Perfusion: An Approach for Improving Utilization Rates. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
6
|
Mallea J, Kon Z, Brown A, Hartwig M, Sanchez P, Keller C, Erasmus D, Dilling D, D'Cunha J, Roberts M, Sketch M, Johnson D, McCurry K. Utilization and Outcomes with Single Lung Transplantation Following Ex Vivo Lung Perfusion Using a Centralized Lung Evaluation System at a Dedicated Facility. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
7
|
Loor G, Garcha P, Huddleston S, Hertz M, Hartwig M, Snyder L, Siddique A, Strah H, Kukreja J, Song T, Jablonski R, Smith M, Walia R, Arjuna A, Lozonschi L, Patel K, Katlaps G, Nemeh H, Suarez E, Huang H, Langer N, Madsen J, Lee A, Dhillon G, MacArthur J, Keshavamurthy S, Nandavaram S, Daneshmand M, Neujahr D, Bush E, Joyce D, Ardehali A, Budev M, McCurry K. Impact of OCS Lung Warm Perfusion Times on Post-Transplant Survival - "Real-World" Experience from Thoracic Organ Perfusion (TOP) Registry. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
8
|
Tak J, Benninger L, Shen K, You J, Carraway H, Lum J, Lane C, Akindipe O, Gadre S, Yun J, McCurry K, Budev M. Combined Lung Liver Transplantation (LLT) in Recipients with Telomeropathy. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
9
|
Ayyat K, Okamoto T, Tantawi A, Sakanoue I, Elgharably H, Ahmad U, Unai S, Yun J, Budev M, McCurry K. Screening for Donor Lung Pulmonary Emboli During Ex-Vivo Lung Perfusion. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
10
|
Loor G, Garcha P, Huddleston S, Hertz M, Hartwig M, Snyder L, Siddique A, Strah H, Kukreja J, Song T, Jablonski R, Smith M, Walia R, Arjuna A, Lozonschi L, Patel K, Katlaps G, Nemeh H, Suarez E, Huang H, Langer N, Madsen J, Lee A, Dhillon G, MacArthur J, Keshavamurthy S, Nandavaram S, Daneshmand M, Neujahr D, Bush E, Joyce D, Ardehali A, Budev M, McCurry K. First Report of the Organ Care System (OCS) Thoracic Organ Perfusion (TOP) Post-Approval Registry. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
11
|
Zhang A, Sun Y, Thomas D, Allen J, Good D, McCurry K, Pei R, Budev M. Humoral Risk Factors Associated to Allograft Dysfunction after Lung Transplantation: The Alert of Non-HLA Auto Antibody and HLA-Donor Specific Antibody (DSA) with Non-DSA HLA Antibody. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
12
|
Ahmad U, Siddiqui H, Rappaport J, Gabbard S, Tang A, Lane C, Akindipe O, Gadre S, Lehr C, Mehta A, Budev M, Bribriesco A, McCurry K, Blackstone E, Murthy S. Should Pre-Transplant Esophageal Dysmotility Preclude Candidacy for Lung Transplantation? J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
13
|
Zhang A, Sun Y, Thomas D, McCurry K, Pei R, Budev M. Humoral Risk Factors Associated to Allograft Dysfunction after Lung Transplantation: The Alert of Non-HLA Auto Antibody and HLA Donor Specific Antibody (DSA) with Non-DSA HLA Antibody. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
14
|
Zhang A, Thomas D, Allen J, McCurry K, Budev M. The New View of Pre-Lung Transplant Determinants for Predicting De Novo Donor Specific Antibody and Transplant Rejection. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
15
|
Van Raemdonck D, Keshavjee S, Levvey B, Cherikh W, Snell G, Erasmus M, Simon A, Glanville A, Clark S, D'Ovidio F, Catarino P, McCurry K, Hertz M, Venkateswaran R, Hopkins P, Inci I, Walia R, Kreisel D, Mascaro J, Dilling D, Camp P, Mason D, Musk M, Burch M, Fisher A, Yusen R, Stehlik J, Cypel M. 5-Year Results from the ISHLT DCD Lung Transplant Registry Confirm Excellent Recipient Survival from Donation after Circulatory Death Donors. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.241] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
16
|
Ardehali A, Van Raemdonck D, Kukreja J, Smith M, Loor G, Rea F, Massard G, De Robertis F, Nagendran J, Moradiellos J, Dhital K, Knosalla C, Bermudez C, Tsui S, Madsen J, Wang I, McCurry K, Deuse T, Thomas P, Tudorache I, Wiegmann B, Schiavon M, Calabrese F, Santelmo N, Olland A, Falcoz P, Varela A, Hertz M, Simon A, Resichenspurner H, Haverich A, Warnecke G. Negative Impact of Primary Graft Dysfunction Grade 3 within the Initial 72 Hours on Short and Long Term Clinical Outcomes in Standard Criteria Double Lung Transplants: Prospective Evidence from the OCS Lung INSPIRE International Trial Results. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.1195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
17
|
Hakim A, Ahmad U, McCurry K, Johnston D, Pettersson G, Budev M, Murthy S, Blackstone E, Tong M. Contemporary Outcomes of ECMO Used as Bridge to Lung Transplantation. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
18
|
Loor G, Camp P, D'Ovidio F, Edwards L, Erasmus M, Glanville A, Hertz M, Hopkins P, Keshavjee S, Levvey B, McCurry K, Musk M, Patterson G, Snell G, Stehlik J, Urban R, Van Raemdonck D. Comparison of Long-Term Survival Outcomes in Recipients of Lungs from Donation After Circulatory Death (DCD) and Donation After Brain Death (DBD). J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
19
|
Warnecke G, Van Raemdonck D, Kukreja J, Smith M, Loor G, Rea F, Massard G, De Robertis F, Nagendran J, Moradiellos J, Dhital K, Knosalla C, Bermudez C, Tsui S, Madsen J, Wang I, McCurry K, Deuse T, Thomas P, Sommer W, Weigmann B, Khun C, Tudorache I, Avsar M, Schiavon M, Santelmo N, Olland A, Falcoz P, Varela A, Hertz M, Simon A, Resichenspurner H, Haverich A, Ardehali A. Mid and Long-Term Clinical Results of OCS Lung INSPIRE International Trial. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.042] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
20
|
Koprivanac M, Budev M, Kelava M, Pettersson G, McCurry K, Johnston D, Houghtaling P, Blackstone E, Murthy S. How Important Is Coronary Artery Disease When Considering Lung Transplant Candidates? J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
21
|
Warnecke G, Van Raemdonck D, Smith M, Kukreja J, Loor G, Rea F, Massard G, De Robertis F, Nagendran J, Moradiellos J, Dhital K, Knosalla C, Bermudez C, Tsui S, Garcia J, Wang I, McCurry K, Wagner F, Leseche G, Thomas P, Weigmann B, Tudorache I, Kühn C, Avsar M, Sommer W, Schiavon M, Santelmo N, Falcoz P, Olland A, Deuse T, Varela A, Simon A, Madsen J, Hertz M, Reichenspurner H, Haverich A, Ardehali A. The Organ Care System (OCS™) Lung INSPIRE International Trial Results. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.255] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
22
|
Warnecke G, van Raemdonck D, Loor G, Smith M, Massard G, Rea F, Simon A, Moradiellos J, Varela A, Nagendran S, Santelmo N, Wiegmann B, Sommer W, Kuehn C, Tudorache I, Avsar M, Nicotra S, Knosalla C, Hetzer R, Tsui S, Bermudez C, Dhital K, Kukreja J, McCurry K, Hertz M, Ardehali A, Haverich A. The INSPIRE International Lung Trial with the Organ Care System Technology (OCS™) - Interim Report. Thorac Cardiovasc Surg 2015. [DOI: 10.1055/s-0035-1544388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
23
|
Warnecke G, Haverich A, van Raemdonck D, Massard G, Santelmo N, Falcoz P, Olland A, Leseche G, Mal H, Thomas P, Rea F, Nicotra S, Schiavon M, Marulli G, Knosalla C, Hetzer R, Simon A, Tsui S, Kukreja J, Bermudez C, Moradiellos F, Varela A, Dhital K, Nagendran J, McCurry K, Ardehali A. The INSPIRE International Lung Trial With the Organ Care System Technology (OCSTM) - Interim Report. Transplantation 2014. [DOI: 10.1097/00007890-201407151-00586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
24
|
Loor G, Weide G, Keshavamurthy S, Hussain S, Topalidis D, Alsalihi M, McCurry K, Koch C. Process Improvement in Thoracic Organ Donor Retrieval: Implementation of a Donor Assessment Checklist. J Heart Lung Transplant 2014. [DOI: 10.1016/j.healun.2014.01.716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
25
|
Askar M, Chan M, McCurry K, Budev M, Schold J. HLA Mismatches Is an Independent Risk Factor for Worse Patient Survival among Lung Transplant Recipients in the United States. J Heart Lung Transplant 2014. [DOI: 10.1016/j.healun.2014.01.511] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
26
|
Warnecke G, Van Raemdonck D, Massard G, Rea F, Smith M, Kukreja J, De Robertis F, Dhital K, Nagendran J, Moradiellos J, Bermudez C, Tsui S, Leseche G, Knosalla C, McCurry K, Thomas P, Loor G, Garcia J, Wang I, Avsar M, Tudorache I, Kühn C, Wiegmann B, Sommer W, Santelmo N, Falcoz P, Olland A, Schiavon M, Marulli G, Di Gregorio G, Simon A, Hetzer R, Varela A, Madsen J, Hertz M, Haverich A, Ardehali A. The INSPIRE Lung International Trial Evaluating the Impact of Portable Ex-vivo Perfusion Using the Organ Care System (OCS™) Lung Technology on Routine Lung Transplant Outcomes. J Heart Lung Transplant 2014. [DOI: 10.1016/j.healun.2014.01.227] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
27
|
Davis D, Azad S, Parker W, Green C, Keshavjee S, McCurry K, Singer L, Budev M, Palmer S. Bile Acid, Not pH Probe or Gastrin Predicts Allograft Function at One Year, From the Prospective RESULT (Reflux Surgery in Lung Transplantation). J Heart Lung Transplant 2014. [DOI: 10.1016/j.healun.2014.01.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
28
|
Askar M, Reville P, Daghstani J, Klingman L, McCurry K, Budev M. The Impact of Repeat HLA Mismatches on the Development of De Novo Donor Specific HLA Antbodies (DSA) in Lung ReTransplants. J Heart Lung Transplant 2013. [DOI: 10.1016/j.healun.2013.01.411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
29
|
Warnecke G, Weigmann B, Van Raemdonck D, Massard G, Santelmo N, Falcoz PE, Olland A, Leseche G, Mal H, Thomas P, Rea F, Marulli G, Knosalla C, Hetzer R, Ardehali A, Kukreja J, Bermudez C, Moradiellos F, Varela A, Dhital K, Nagendran J, McCurry K, Haverich A. The INSPIRE International Lung Trial with the Organ Care System Technology (OCS™). J Heart Lung Transplant 2013. [DOI: 10.1016/j.healun.2013.01.020] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
30
|
Askar M, Reville P, Klingman L, Zhang A, Schold J, Daghstani J, Budev M, McCurry K, Farver C. Histological Findings of Bronchial Biopsies and De Novo Donor Specific HLA Antibodies: Comparing Notes. J Heart Lung Transplant 2013. [DOI: 10.1016/j.healun.2013.01.402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
31
|
Zeltzer S, Fadul R, Askar M, Lane C, Garcha P, Akindipe O, Tang A, Schold J, McCurry K, Petterson G, Mason D, Murthy S, Johnston D, Budev M. HLA Allosensitization in ECMO as a Bridge to Lung Transplantation. J Heart Lung Transplant 2013. [DOI: 10.1016/j.healun.2013.01.405] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
32
|
Okamoto T, Tang X, Farver C, McCurry K. 396 Supercooling Preservation at −2°C Protects Rat Lung Grafts from Ischemia-Reperfusion Injury Via Elevated Expression of Heat Shock Protein 70. J Heart Lung Transplant 2011. [DOI: 10.1016/j.healun.2011.01.404] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
33
|
Mason D, Murthy S, Yun J, Machuzak M, Shrestha R, Avery R, McCurry K, Budev M, Pettersson G. Lung Transplantation in a Recipient with Novel 2009 H1N1 Influenza: Lessons Learned. Thorac Cardiovasc Surg 2011; 59:126-7. [DOI: 10.1055/s-0030-1250240] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
34
|
Teuteberg J, Shullo M, Zomak R, Bhama J, Toyoda Y, Bermudez C, McNamara D, Kormos R, McCurry K. 429: Alemtuzumab Induction Facilitates Steroid-Free Immunosuppression in Human Cardiac Transplantation – One Year Outcomes. J Heart Lung Transplant 2009. [DOI: 10.1016/j.healun.2008.11.436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
35
|
Teuteberg J, Shullo M, Zomak R, Toyoda Y, Bermudez C, McNamara D, Kormos R, McCurry K. 391: Alemtuzumab Induction Facilitates Steroid-Free Maintenance Immunosuppresion in Human Cardiac Transplantation. J Heart Lung Transplant 2008. [DOI: 10.1016/j.healun.2007.11.402] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
36
|
Teuteberg J, Novack J, Shullo M, Simon M, Kathleen L, Coyne J, Siegenthaler M, McCurry K, McNamara D, Kormos R. 198: Renal Dysfunction before Ventricular Assist Impacts Renal Function Post-Transplant, Despite Improvements in Renal Function during Ventricular Support. J Heart Lung Transplant 2008. [DOI: 10.1016/j.healun.2007.11.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
37
|
McCurry K, Jeevanandam V, Mihaljevic T, Couper G, Elanwar M, Saleh H, Ardehali A. 294: Prospective Multi-Center Safety and Effectiveness Evaluation of the Organ Care System Device for Cardiac Use (PROCEED). J Heart Lung Transplant 2008. [DOI: 10.1016/j.healun.2007.11.303] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
38
|
Nguyen D, Bhama J, Bermudez C, Toyoda Y, Thacker Y, Teuteberg J, McCurry K, Kormos R. 464: Donor age influences orthotopic heart transplant (OHTX) outome independent of traditional risk factors. J Heart Lung Transplant 2007. [DOI: 10.1016/j.healun.2006.11.487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
39
|
Teuteberg J, Weaver S, Stanford E, Simon M, McNamara D, Toyoda Y, Bermudez C, McCurry K, Kormos R. 123: Survival and weight loss in the obese patient after the implantation of ventricular assist devices. J Heart Lung Transplant 2007. [DOI: 10.1016/j.healun.2006.11.139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
40
|
Crespo M, Raza K, Johnson B, McCurry K, Pilewski J, Husain S. 66. J Heart Lung Transplant 2006. [DOI: 10.1016/j.healun.2005.11.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
41
|
Girnita A, Ionescu D, Yousem S, Duquesnoy R, Spichty K, Pilewski J, Studer S, Johnson B, McCurry K, Zeevi A. Donor-specific anti-HLA alloantibodies are associated with subendothelial C4d deposition and chronic lung allograft dysfunction. Hum Immunol 2005. [DOI: 10.1016/j.humimm.2005.08.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
42
|
Spichty K, Bentlejewski C, Girnita A, McDade K, Husain S, Pilewski J, Zaldonis D, Britz J, Kowalski R, Post D, McCurry K, Zeevi A. T cell immunity in lung transplant recipients. Hum Immunol 2005. [DOI: 10.1016/j.humimm.2005.08.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
43
|
Zeevi A, Girnita A, Spichty K, Zaldonis D, Husain S, McDade K, Pilewski J, McCurry K. Campath preconditioning followed by low maintenance immunosuppression in lung transplant recipients. Hum Immunol 2005. [DOI: 10.1016/j.humimm.2005.08.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
44
|
Zheng HX, Zeevi A, McCurry K, Schuetz E, Webber S, Ristich J, Zhang J, Iacono A, Dauber J, McDade K, Zaldonis D, Lamba J, Burckart GJ. The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients. Transpl Immunol 2005; 14:37-42. [PMID: 15814280 DOI: 10.1016/j.trim.2004.11.001] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2004] [Accepted: 11/09/2004] [Indexed: 11/17/2022]
Abstract
Persistent rejection in the face of treatment and multiple episodes of rejection are associated with the development of chronic rejection and graft loss in solid organ transplantation. The factors that create an environment for rejection that persists in the face of treatment are as yet not understood. The objective of this study was to evaluate the risk factors, including human multidrug resistance gene (MDR1), cytochrome P4503A5 (CYP3A5) and cytokine gene polymorphisms, associated with acute persistent rejection (APR) in lung transplant patients. One hundred and twenty-five adult lung transplant patients were studied. MDR1 G2677T, C3435T and CYP3A5 polymorphisms were assessed by direct sequencing of the polymorphic region in patient DNA. Cytokine genotyping for five cytokines was performed using the polymerase chain reaction-sequence specific primers (PCR-SSP) technique. Multivariate regression analysis was used to identify the predictors of acute persistent rejection. The dependent variable was the presence or absence of acute persistent rejection based on lung biopsies during the first postoperative year. The independent variables were MDR1 G2677T and C3435T, CYP4503A5 and cytokine polymorphisms, survival status, age, gender, survival days and HLA mismatches. The MDR1 C3435T polymorphism and age were independently associated with acute persistent rejection (p = 0.025, odds ratio = 0.29, 95% CI 0.1-0.86 and p = 0.016, odds ratio = 0.94, 95% CI 0.89-0.98, respectively). For the MDR1 C3435T polymorphism, 72% of patients with the C allele had acute persistent rejection in comparison to 52% for TT patients (p = 0.04). For age, a significant difference was found between the nonrejection group and the rejection group (mean+/-S.D. 52.1+/-11.2 vs. 44.4+/-12.3, p = 0.01). This is the first report of the association of a drug disposition genotype with drug-resistant acute rejection in organ transplant patients. The major predictor of acute persistent rejection in the first postoperative year for lung transplant patients was the MDR1 C3435T genotype. This association could be due to drug resistance, altered drug disposition or other immunologic effects associated with P-glycoprotein (P-gp) function. Future prospective treatment algorithms should be developed that will incorporate the knowledge of gene polymorphisms into treatment regimens to improve the outcome following lung transplantation.
Collapse
Affiliation(s)
- H X Zheng
- School of Pharmacy, University of Southern California, 1985 Zonal Avenue, PSC-100, Los Angeles, CA 90033, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Hare J, Perrone S, Eisen H, McCurry K, Hauptman P, Simonsen S, Crespo M, Arizon J, Kobashigawa J, Jarcho J. Everolimus in de novo cardiac transplant recipients: 48-month (M) follow-up. J Heart Lung Transplant 2005. [DOI: 10.1016/j.healun.2004.11.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
46
|
Zeevi A, Girnita A, McCurry K, Awad M, Burckart G, Duquesnoy R, Dauber J, Griffith B, Iacono A. Increased incidence of severe lung allograft acute rejection in patients exhibiting HLA-specific antibodies. J Heart Lung Transplant 2003. [DOI: 10.1016/s1053-2498(02)00969-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
47
|
Girnita A, Awad M, McCurry K, Spichty K, Burckart G, Duquesnoy R, Iacono A, Grgurich W, Dauber J, Griffith B, Zeevi A. Clinical relevance of hla class I and class II antibodies detected by ELISA in lung transplantation. J Heart Lung Transplant 2002. [DOI: 10.1016/s1053-2498(01)00686-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
48
|
Vilchez RA, McCurry K, Dauber J, Iacono A, Keenan R, Zeevi A, Griffith B, Kusne S. The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis 2001; 33:2004-8. [PMID: 11702289 DOI: 10.1086/324348] [Citation(s) in RCA: 65] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2001] [Revised: 07/12/2001] [Indexed: 11/03/2022] Open
Abstract
Human parainfluenza virus (HPIV) is a common cause of seasonal respiratory tract infections. However, little is known about the clinical presentation and impact of HPIV infections in lung transplant recipients. We reviewed HPIV infections at the University of Pittsburgh Medical Center. From January 1990 through May 2000, 32 cases of HPIV infection were identified. HPIV infection was found in 24 lung transplant recipients (75%), all of whom were included in the study group. Diagnosis was established at a median of 2.1 years after transplantation (range, 0.6-5 years). Presenting symptoms included cough (17 patients), shortness of breath (16), and temperature elevation (4). Respiratory failure occurred in 5 patients (21%). The HPIV serotypes were HPIV-1 (7 patients), HPIV-2 (2), and HPIV-3 (15 [63%]). Twenty-two patients underwent transbronchial biopsy, and 18 (82%) showed signs of acute allograft rejection. Seven patients (32%) subsequently were found to have bronchiolitis obliterans.
Collapse
Affiliation(s)
- R A Vilchez
- Department of Medicine, University of Pittsburgh Medical Center, and Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, USA
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Pigula FA, Gandhi SK, Ristich J, Stukus D, McCurry K, Webber SA, Keenan R, Griffith BP, Kormos R. Cardiopulmonary transplantation for congenital heart disease in the adult. J Heart Lung Transplant 2001; 20:297-303. [PMID: 11257555 DOI: 10.1016/s1053-2498(00)00229-1] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
BACKGROUND Patients surviving into adulthood with congenital heart disease (CHD) often succumb to progressive cardiopulmonary dysfunction. For these patients transplantation is often considered. METHODS We performed a retrospective review of 69 adults (age >18 years) with CHD transplanted between 1984 and 1999. RESULTS We evaluated 31 heart-lung (HLTxp), 30 lung (LTxp), and 8 heart (HTxp) transplants performed in 22 men and 47 women with CHD. Mean age was 37 +/- 10 years with a mean follow-up of 3.1 +/- 3.5 years. A concomitant cardiovascular procedure was performed in 1 HLTxp, 23 LTxp, and 2 HTxp. Early mortality (>30 days) was 26% (8/31) for HLTxp, mostly due to bleeding. Early LTxp mortality was 23% (7/30), largely due to graft failure. One and 3-year survival was similar in adults transplanted for CHD and adults transplanted for other disease. Early mortality among HTxp recipients was 50% (4/8) from rejection or technical complications. Survival for patients undergoing HLTxp versus LTxp with cardiac repair was similar. When examined by era, the survival of patients transplanted for CHD between 1992 and 1999 was greater than that of patients transplanted between 1984 and 1991. CONCLUSIONS Adults undergoing HLTxp and LTxp for CHD can expect survival comparable to that of non-CHD adults. In the presence of a reparable cardiac lesion, LTxp with cardiovascular repair for CHD is an attractive option, optimizing organ allocation. Specific technical concerns are discussed. Survival of adults undergoing cardiopulmonary transplantation for CHD has improved over time.
Collapse
Affiliation(s)
- F A Pigula
- Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Affiliation(s)
- M Kubo
- University of Pittsburgh, Pittsburgh, PA, USA
| | | | | | | | | | | |
Collapse
|